Case report of penile cancer recurrence treated with cetuximab combined with anlotinib

Penile squamous cell carcinoma with pelvic lymph node metastases/recurrence has a poor prognosis. We reported a case with recurrent pSCC was administered cetuximab and anlotinib after failure of first‐line treatment and achieved an effective response. Cetuximab combined with anlotinib may be a new c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Shuang, Liu, Yan‐Yang, Liu, Tao, Zhang, Yu, Luo, De‐Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847399/
https://www.ncbi.nlm.nih.gov/pubmed/35223013
http://dx.doi.org/10.1002/ccr3.5443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847399/
https://www.ncbi.nlm.nih.gov/pubmed/35223013
http://dx.doi.org/10.1002/ccr3.5443

Ejemplares similares